Research shows that chronic conditions, including Immune Thrombocytopenia (ITP), can profoundly impact a person’s mental health.
From 1 January 2023, the maximum cost of general prescriptions under the PBS will fall for the first time in the 75-year history of the Pharmaceutical Benefits Scheme (PBS). It’s important that patients understand the changes and how they will affect them.
Over the last 3-6 months, ITP Australia has been working behind the scenes to develop some important patient collateral and materials and add more information across ITPAustralia.org.au.
We are very much aware that getting good quality sleep and developing regular sleep patterns are important to our overall health and well-being. Good sleep = Good health.
Welcome to the 2022 Spring Edition The Count. A quarterly newsletter created to update the ITP community on the latest updates and activities by ITP Australia and in the world of Immune Thrombocytopenia.
In this edition, we highlight the activities planned for 2022 ITP Awareness Week and how you can get involved, our recent trip to Seattle, Washington USA to meet with other international patient associations, focus on the importance of sleep, launch our NEW patient resources, and so much more!
Many of you have had the pleasure of meeting or hearing from Patricia. While she joined ITP Australia in early 2022, her ITP Journey started many years earlier. Read her story here.
It was fabulous having the opportunity to see our Global Alliance members face to face again in 2022. After a number of years of waking at 1 am to join Video Meetings and hear what everyone was up to, it was great to be in the same room with many of our colleagues.
HAVE YOUR SAY: Submit your letter to us, and we will hand deliver them when we travel to Canberra on Monday 5th September 2022.
The PBAC recommends removing restrictions to make it easier for ALL ITP Patients to access TPORAs.
Missed the ITP Australia Virtual Patient Conference for 2022, or would like to revisit one or more of the presentations? View them here.
A new parliamentary report, ‘The New Frontier: Delivering better health for all Australians’, is recommending significant reforms to the health care system to ensure Australians have better and faster access to the wave of new medicines and technologies.
The PBAC recommends a change for all listings and brands of Rituximab to be added to the Unrestricted Benefits listings.